[HTML][HTML] Immunotherapie van HPV-gerelateerde tumoren van cervix en vulva
In nauwe samenwerking met de afdelingen Klinische Oncologie, Pathologie en Klinische
Farmacie en Toxicologie wordt onderzoek gedaan naar immunotherapeutische aspecten …
Farmacie en Toxicologie wordt onderzoek gedaan naar immunotherapeutische aspecten …
Efeito do fator de necrose tumoral-alfa (TNF-α) sobre células imortalizadas por papilomavírus humano (HPV)
EMB Pierulivo - teses.usp.br
A infecção por papilomavírus humano (HPV) é o principal fator de risco para o
desenvolvimento de neoplasias intra-epiteliais cervicais, as lesões precursoras do …
desenvolvimento de neoplasias intra-epiteliais cervicais, as lesões precursoras do …
Human Papillomavirus Vaccines
Persistent high-risk type human papillomavirus (HPV) infection has been identified as a
necessary, albeit not sufficient, cause of cervical cancer and it is responsible for 5.2% of all …
necessary, albeit not sufficient, cause of cervical cancer and it is responsible for 5.2% of all …
The anti-lung cancer activity of a modified HPV 16 type mE6Δ/mE7 fusion protein based vaccine in an experimental animal model
Z Xiaoshan, Z Qingzheng, Q Xinlai… - Zhongguo Fei Ai …, 2004 - search.proquest.com
目的 研究经改造的 HPV16 E6/E7 蛋白质疫苗 (HPV16 mE6△/mE7) 对表达 HPV16 E6 和 E7
的小鼠肺癌细胞的体内生长抑制作用, 为肺癌免疫治疗提供新线索. 方法 预防性实验: 对 …
的小鼠肺癌细胞的体内生长抑制作用, 为肺癌免疫治疗提供新线索. 方法 预防性实验: 对 …
DEVELOPMENT OF HPV VACCINES FOR HPV-ASSOCIATED HEAD AND NECK SQUAMOUS CELL CARCINOMA.
ML Gillison, TC Wu - Critical Reviews in Oral Biology & …, 2003 - search.ebscohost.com
High-risk genotypes of the human papillomavirus (HPV), particularly HPV type 16, are found
in a distinct subset of head and neck squamous cell carcinomas (HNSCC). Thus, these HPV …
in a distinct subset of head and neck squamous cell carcinomas (HNSCC). Thus, these HPV …
[图书][B] Cultured Dendritic Cells for Cancer Immunotherapy
A Clayton - 2002 - search.proquest.com
There is increasing interest in the development of targeted therapies for malignant disease,
mainly as a result of the shortcomings of conventional chemotherapy for most solid …
mainly as a result of the shortcomings of conventional chemotherapy for most solid …
[PDF][PDF] ПЕРСПЕКТИВНЫЕ НАПРАВЛЕНИЯ В СОЗДАНИИ НОВЫХ ВАКЦИН ПРОТИВ ПАПИЛЛОМАВИРУСНОЙ ИНФЕКЦИИ
ТН Никитина, НМ Раевская, ИЛ Соловьева… - ЦИТОКИНЫ, 2002 - researchgate.net
Папилломавирусная инфекция относится к наиболее распространенным вирусным
инфекциям во всем мире. Высокоонкогенные типы вируса папилломы человека (ВПЧ) …
инфекциям во всем мире. Высокоонкогенные типы вируса папилломы человека (ВПЧ) …
[图书][B] Investigation into host, viral and tumour encoded factors influencing immune evasion in cervical cancer
CS Brady - 2000 - search.proquest.com
Infection with the human papillomavirus (HPV) is necessary but not sufficient alone for the
development of cervical carcinoma. A finely balanced virus-host relationship exists which on …
development of cervical carcinoma. A finely balanced virus-host relationship exists which on …
[PDF][PDF] Human Papillomavirus Type 33 E7 Peptides
KF Neukirch, A Necker, J Markus - 2000 - Citeseer
Several characteristics make human papillomavirus (HPV) amenable to vaccination. Anti-
HPV-directed vaccines are based on the observation that HPV E6 and E7 oncoproteins are …
HPV-directed vaccines are based on the observation that HPV E6 and E7 oncoproteins are …
Recognition of human tumours: viral antigens as immunological targets for cytotoxic T cells
S Man - Cancer Immunology, 2001 - Springer
It has been estimated that some 15% of human cancers are associated with viral infection
and the use of more sensitive molecular techniques may well reveal more. Preventing viral …
and the use of more sensitive molecular techniques may well reveal more. Preventing viral …